Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13482)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pei RJ, Chen XW, Lu MJ. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World J Gastroenterol 2014; 20(33): 11618-11629 [PMID: 25206268 DOI: 10.3748/wjg.v20.i33.11618] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i33/11618.htm |
| Number | Citing Articles |
| 1 |
Marina Campos-Valdez, Hugo C. Monroy-Ramírez, Juan Armendáriz-Borunda, Laura V. Sánchez-Orozco. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability. Viruses 2021; 13(6): 1167 doi: 10.3390/v13061167
|
| 2 |
Anteneh Getachew, Muzammal Hussain, Xinping Huang, Yinxiong Li. Toll-like receptor 2 signaling in liver pathophysiology. Life Sciences 2021; 284: 119941 doi: 10.1016/j.lfs.2021.119941
|
| 3 |
Jiayi Wang, Lingyao Du, Hong Tang. Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.784172
|
| 4 |
Mengjie Fan, Jing Wang, Sa Wang, Tengyan Li, Hong Pan, Hankui Liu, Huifang Xu, Daria V. Zhernakova, Stephen J. O’Brien, Zhenru Feng, Le Chang, Erhei Dai, Jianhua Lu, Hongli Xi, Yanyan Yu, Jianguo Zhang, Binbin Wang, Zheng Zeng. New Gene Variants Associated with the Risk of Chronic HBV Infection. Virologica Sinica 2020; 35(4): 378 doi: 10.1007/s12250-020-00200-x
|
| 5 |
Hongjuan You, Suping Qin, Fulong Zhang, Wei Hu, Xiaocui Li, Dongsheng Liu, Fanyun Kong, Xiucheng Pan, Kuiyang Zheng, Renxian Tang. Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.829923
|
| 6 |
Ya-Juan Wang., Li Yang, Jian-Ping Zuo. Recent developments in antivirals against hepatitis B virus. Virus Research 2016; 213: 205 doi: 10.1016/j.virusres.2015.12.014
|
| 7 |
Baohui Fu, Yue Ji, Shouci Hu, Tong Ren, Maheshkumar Satishkumar Bhuva, Ge Li, Hongtao Yang, Heidar Sharafi. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis. PLOS ONE 2020; 15(1): e0227532 doi: 10.1371/journal.pone.0227532
|
| 8 |
Jia Li, Thekla Kemper, Ruth Broering, Jieliang Chen, Zhenghong Yuan, Xueyu Wang, Mengji Lu. Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.804011
|
| 9 |
Sahar Janfeshan, Ramin Yaghobi, Akram Eidi, Mohammad Hossein Karimi, Bita Geramizadeh, Seyed Ali Malekhosseini, Farshid Kafilzadeh. Study the Cross-talk Between Hepatitis B Virus Infection and Interferon Regulatory Factors in Liver Transplant Patients. Hepatitis Monthly 2017; 17(11) doi: 10.5812/hepatmon.12426
|
| 10 |
Wei Li, Hua Zhang, Ao Ren, Wei Fan, Qiong Qin, Ling Zhao, Ruidong Ma, Qiufeng Peng, Shiqiao Luo. Systemic lupus erythematosus is associated with lower risk of hepatitis B virus infection: A multivariable Mendelian randomization study in East Asian population. Journal of Medical Virology 2023; 95(11) doi: 10.1002/jmv.29226
|
| 11 |
Shuang Li, Yuanyang Xie, Changyin Yu, Chunfu Zheng, Zucai Xu. The battle between host antiviral innate immunity and immune evasion by cytomegalovirus. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05369-y
|
| 12 |
Ejuan Zhang, Mengji Lu. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Medical Microbiology and Immunology 2015; 204(1): 11 doi: 10.1007/s00430-014-0370-1
|
| 13 |
Ashish Goyal, Ruy Ribeiro, Alan Perelson. The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans. Viruses 2017; 9(11): 350 doi: 10.3390/v9110350
|
| 14 |
Shuhui Liu, Kaitao Zhao, Xi Su, Lu Lu, He Zhao, Xianwen Zhang, Yun Wang, Chunchen Wu, Jizheng Chen, Yuan Zhou, Xue Hu, Yanyi Wang, Mengji Lu, Xinwen Chen, Rongjuan Pei, Haitao Guo. MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication. PLOS ONE 2017; 12(1): e0169701 doi: 10.1371/journal.pone.0169701
|
| 15 |
Martin K. Thomsen, Ramya Nandakumar, Daniela Stadler, Antje Malo, Roser Marin Valls, Fan Wang, Line S. Reinert, Frederik Dagnæs‐Hansen, Anne Kruse Hollensen, Jacob Giehm Mikkelsen, Ulrike Protzer, Søren R. Paludan. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology 2016; 64(3): 746 doi: 10.1002/hep.28685
|
| 16 |
Ping Lei, Guan-Xin Shen, Fu-Sheng Wang, Qin Ning, Hong Ren, Wei-Ming Yan, Di Wu. Acute Exacerbation of Chronic Hepatitis B. 2019; : 223 doi: 10.1007/978-94-024-1606-0_5
|
| 17 |
Sen Wang, Yuxin Chen, Xuejing Xu, Wei Hu, Han Shen, Junhao Chen. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Oncotarget 2017; 8(60): 102437 doi: 10.18632/oncotarget.22261
|
| 18 |
Piotr Rzymski, Dorota Zarębska-Michaluk, Robert Flisiak. Could chronic HBV infection explain Beethoven's hearing loss? Implications for patients currently living with hepatitis B. Journal of Infection 2023; 87(3): 171 doi: 10.1016/j.jinf.2023.06.006
|
| 19 |
Asi He, Wei Wang, Yang Xia, Xiaoping Niu, Abraham Wall Medrano. A Network Pharmacology Approach to Explore the Mechanisms of Artemisiae scopariae Herba for the Treatment of Chronic Hepatitis B. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6614039
|
| 20 |
Miao-Qing Zhang, Qiong Zhao, Jing-Pu Zhang. A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells. Autophagy 2020; 16(12): 2167 doi: 10.1080/15548627.2020.1719681
|
| 21 |
Andreas F. R. Sommer, Lise Rivière, Bingqian Qu, Kerstin Schott, Maximilian Riess, Yi Ni, Caitlin Shepard, Esther Schnellbächer, Malin Finkernagel, Kiyoshi Himmelsbach, Karin Welzel, Nadja Kettern, Christian Donnerhak, Carsten Münk, Egbert Flory, Juliane Liese, Baek Kim, Stephan Urban, Renate König. Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle. Scientific Reports 2016; 6(1) doi: 10.1038/srep26616
|
| 22 |
Fanyun Kong, Hongjuan You, Delong Kong, Kuiyang Zheng, Renxian Tang. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis. Virology Journal 2019; 16(1) doi: 10.1186/s12985-019-1183-z
|
| 23 |
Dimpu Gogoi, Biswajyoti Borkakoty, Dipankar Biswas, Jagadish Mahanta. Activation and Exhaustion of Adaptive Immune Cells in Hepatitis B Infection. Viral Immunology 2015; 28(7): 348 doi: 10.1089/vim.2014.0115
|
| 24 |
Md. Golzar Hossain, Keiji Ueda, Yanjin Zhang. Regulation of Hepatitis B Virus Replication by Modulating Endoplasmic Reticulum Stress (ER‐Stress). International Journal of Microbiology 2024; 2024(1) doi: 10.1155/2024/9117453
|
| 25 |
Qian-Guo Mao, Hui-Qing Liang, Ya-Lin Yin, Jin-Mo Tang, Jia-En Yang, Chun-Cheng Wu, Yue Chen, Man-Ying Zhang, Yao-Yu Liu, Xiao-Ting Zheng, Lin-Yi Zhuang, Shao-Dong Chen. Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B. Clinics and Research in Hepatology and Gastroenterology 2022; 46(1): 101758 doi: 10.1016/j.clinre.2021.101758
|
| 26 |
Pensiri Yosyingyong, Ratchada Viriyapong. Global stability and optimal control for a hepatitis B virus infection model with immune response and drug therapy. Journal of Applied Mathematics and Computing 2019; 60(1-2): 537 doi: 10.1007/s12190-018-01226-x
|
| 27 |
Robert G. Gish, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, David L. Lewis, Thomas Schluep. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Research 2015; 121: 47 doi: 10.1016/j.antiviral.2015.06.008
|
| 28 |
Li Wang, Kai Wang, Zhi-Qiang Zou. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World Journal of Hepatology 2015; 7(30): 2980-2991 doi: 10.4254/wjh.v7.i30.2980
|
| 29 |
Sina Feustel, Fabiola Ayón-Pérez, Ana Sandoval-Rodriguez, Roberto Rodríguez-Echevarría, Homero Contreras-Salinas, Juan Armendáriz-Borunda, L. V. Sánchez-Orozco. Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells. Journal of Immunology Research 2017; 2017: 1 doi: 10.1155/2017/6063850
|
| 30 |
Isha Sengupta, Dipanwita Das, Shivaram Prasad Singh, Runu Chakravarty, Chandrima Das. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence. Journal of Biological Chemistry 2017; 292(50): 20379 doi: 10.1074/jbc.M117.796839
|